|
1
|
Kebebew E and Clark OH: Differentiated
thyroid cancer: “complete” rational approach. World J Surg.
24:942–951. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ringel MD and Ladenson PW: Controversies
in the follow-up and management of well-differentiated thyroid
cancer. Endocr Relat Cancer. 11:97–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caron NR and Clark OH: Well differentiated
thyroid cancer. Scand J Surg. 93:261–271. 2004.PubMed/NCBI
|
|
4
|
Patel KN and Shaha AR: Poorly
differentiated and anaplastic thyroid cancer. Cancer Control.
13:119–128. 2006.PubMed/NCBI
|
|
5
|
Cushing SL, Palm CE, Audet N, Eski S,
Walfish PG and Freeman JL: Prognostic factors in
well-differentiated thyroid carcinoma. Laryngoscope. 114:2110–2115.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mazzaferri EL: An overview of the
management of papillary and follicular thyroid carcinoma. Thyroid.
9:421–427. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akslen LA and LiVolsi VA: Prognostic
significance of histologic grading compared with subclassification
of papillary thyroid carcinoma. Cancer. 88:1902–1908. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sugg SL, Zheng L, Rosen IB, Freeman JL,
Ezzat S and Asa SL: ret/PTC-1, -2 and -3 oncogene rearrangements in
human thyroid carcinomas: implications for metastatic potential? J
Clin Endocrinol Metab. 81:3360–3365. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tuttle RM: Differentiated thyroid cancer:
Clinicopathologic staging. http://www.uptodate.com/contents/differentiated-thyroid-cancer-clinicopathologic-stagingOctober
6th–2013
|
|
10
|
DeGroot LJ, Kaplan EL, McCormick M and
Straus FH: Natural history, treatment, and course of papillary
thyroid carcinoma. J Clin Endocrinol Metab. 71:414–424. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kebebew E and Clark OH: Differentiated
thyroid cancer: “Complete” rational approach. World J Surg.
24:942–951. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rami-Porta R, Crowley JJ and Goldstraw P:
The revised TNM staging system for lung cancer. Ann Thorac
Cardiovasc Surg. 15:4–9. 2009.PubMed/NCBI
|
|
13
|
Weetman AP: Expert Consult:
ThyroiditisConn's Current Therapy 2012. Bope ET and Kellerman RD:
Elsevier Saunders; Philadelphia, USA: 2012
|
|
14
|
Elisei R, Molinaro E, Agate L, et al: Are
the clinical and pathological features of differentiated thyroid
carcinoma really changed over the last 35 years? Study on 4187
patients from a single Italian institution to answer this question.
J Clin Endocrinol Metab. 95:1516–1527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka K, Sonoo H, Saito W, Ohta Y, Shimo
T, Sohda M, Yamamoto Y and Kurebayashi J: Analysis of clinical
outcome of patients with poorly differentiated thyroid carcinoma.
ISRN Endocrinol. 2011:3080292011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holler T, Theriault J, Payne RJ, Clark J,
Eski S and Freeman JL: Prognostic factors in patients with multiple
recurrences of well-differentiated thyroid carcinoma. J Oncol.
2009:6503402009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Palme CE, Waseem Z, Raza SN, Eski S,
Walfish P and Freeman JL: Management and outcome of recurrent
well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck
Surg. 130:819–824. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fonseca E, Soares P, Rossi S and
Sobrinho-Simões M: Prognostic factors in differentiated thyroid
gland carcinoma. Pathologe. 18:275–285. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akslen LA, Myking AO, Salvesen H and
Varhaug JE: Prognostic importance of various clinicopathological
features in papillary thyroid carcinoma. Eur J Cancer. 29A:44–51.
1992.PubMed/NCBI
|
|
20
|
Mazzaferri EL and Jhiang SM: Long-term
impact of initial surgical and medical therapy on papillary and
follicular thyroid cancer. Am J Med. 97:418–428. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baloch ZW and LiVolsi VA: Prognostic
factors in well-differentiated follicular-derived carcinoma and
medullary thyroid carcinoma. Thyroid. 11:637–645. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schlumberger M and Pacini F: Thyroid
tumors. 2nd. Nucléon Editions; Paris, France: pp. 18–24. 2003
|
|
23
|
Lin JD, Chao TC and Hsueh C: Clinical
characteristics of poorly differentiated thyroid carcinomas
compared with those of classical papillary thyroid carcinomas. Clin
Endocrinol (Oxf). 66:224–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishida T, Katayama M, Tsujimoto M,
Nakamura J and Matsuda H: Clinicopathological significance of
poorly differentiated thyroid carcinoma. Am J Surg Pathol.
23:205–211. 1999. View Article : Google Scholar : PubMed/NCBI
|
